Stocksigma LogoStocksigma Logo

Max Healthcare Approves ₹87.87 Crore Equity Infusion into Subsidiary Kalinga Hospital

On 3rd Sep'26, Max Healthcare approved a ₹87.87 Crore cash infusion into its existing subsidiary, Kalinga Hospital Ltd

Max Healthcare Approves ₹87.87 Crore Equity Infusion into Subsidiary Kalinga Hospital

Max Healthcare Institute Ltd · Others (Uncategorized) · 03 Sept 2026, 8:59 pm

Max Healthcare Approves ₹87.87 Crore Equity Infusion into Subsidiary Kalinga Hospital On 3rd Sep'26, Max Healthcare approved a ₹87.87 Crore cash infusion into its existing subsidiary, Kalinga Hospital Ltd. (KHL), via a rights issue subscription. Expected to close within 15 days, the capital will fund KHL’s capex, modernization initiatives, and capital structure optimization while strengthening clinical capabilities. KHL reported FY26 operating revenues of ~₹155.64 Crore and a paid-up capital of ₹21.54 Crore. The strategic transaction is exempt from SEBI's related-party restrictions and supports broader corporate requirements without altering the parent's primary line of business.

Original exchange filing (PDF)

More announcements from Max Healthcare Institute Ltd

All Max Healthcare Institute Ltd announcements